Firstly, the mRNA levels of Cyclin B1, CDK1, PLK1 and Aurora A are significantly higher in primary localized prostate cancer than those in benign prostatic hyperplasia, and the levels of these regulators are further elevated in prostate cancer with metastasis compared with those in primary localized prostate cancer [28]. This evidence concerns the gene PLK1 and benign prostatic hyperplasia.